Therapeutics Lifecycle SIG

Join us in June for a discussion with representatives from Ziegler on how investors are evaluating the decentralized clinical trial space and implications on patient recruitment and retention.

The Therapeutic Lifecycle SIG focuses holistically on the full lifecycle of therapeutic development, from clinical trials to in-market use. Initial work will focus on clinical research, regulatory submission, in-market pharmaceuticals, and connecting research technology solutions to in-market technology solutions.